Like virtually every other industry, health care is increasingly prioritizing digital transformation. The sector is unique, ...

Hope for aggressive breast cancer. Survivors and doctors discuss breakthroughs, fears, and the need for inclusive research.

Following peer review, applications are passed to the NIH’s funding institutes and centers, such as the National Institute of Allergy and Infectious Diseases (NIAID) or the National Cancer Institute ...

A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

Black Americans are more willing to participate in medical studies led by Black doctors and researchers, perceiving them as ...

Arthur Caplan, PhD, is the Drs. William F. and Virginia Connolly Mitty Professor and founding head of the Division of Medical Ethics at NYU Grossman School of Medicine. Lisa Kearns, MS, MA, is a ...

IQVIA (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions and clinical research services to the healthcare and life sc ...

Multiracial growth impacts clinical trials. Explore challenges in race classification, health disparities, and genomic profiling.

Computer vision artificial intelligence can improve patient care, but reaping its full benefits relies on careful training, ...

Dr. Joyce A. O’Shaughnessy, described by her peers as a ‘legend in the space,’ leads breast cancer research and treatment ...

Find out what led biotech to a situation where women are underrepresented in clinical trials and how the industry is ...

Machine learning is driving efforts to classify MS into distinct subtypes that may predict disease course, but two experts debate whether this will advance patient care.